2022 annual financial data
Syndax Pharmaceuticals 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -105.61%.
Operating income was -151,757,000 USD and net income was -143,749,000 USD.
Operating cash flow was -133,675,000 USD.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 126,576,000 USD
- Operating income
- -151,757,000 USD
- Net income
- -143,749,000 USD
- Operating cash flow
- -133,675,000 USD